Skip to main content

Table 1 Incidence and prevalence of Waldenström macroglobulinemia between 2003 and 2016

From: Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study

Year

Incident cases

Prevalent cases

Incidence per 105/ya

Prevalence per 105/yb

Total

Male

Female

Total

Male

Female

Total

Male

Female

Total

Male

Female

2003

14

8

6

19

12

7

0.03

0.03

0.02

0.04

0.05

0.03

2004

18

16

2

33

26

7

0.04

0.07

0.01

0.07

0.11

0.03

2005

15

13

2

45

36

9

0.03

0.05

0.01

0.09

0.15

0.04

2006

19

15

4

57

45

12

0.04

0.06

0.02

0.12

0.18

0.05

2007

21

20

1

66

55

11

0.04

0.08

0.00

0.13

0.22

0.04

2008

25

17

8

81

63

18

0.05

0.07

0.03

0.16

0.25

0.07

2009

28

22

6

94

71

23

0.06

0.09

0.02

0.19

0.28

0.09

2010

25

17

8

107

77

30

0.05

0.07

0.03

0.21

0.30

0.12

2011

39

28

11

132

99

33

0.08

0.11

0.04

0.26

0.39

0.13

2012

45

37

8

149

115

34

0.09

0.15

0.03

0.29

0.45

0.13

2013

37

27

10

162

122

40

0.07

0.11

0.04

0.32

0.48

0.16

2014

43

29

14

182

136

46

0.08

0.11

0.05

0.35

0.53

0.18

2015

45

36

9

202

151

51

0.09

0.14

0.03

0.39

0.59

0.20

2016

53

41

12

216

161

55

0.10

0.16

0.05

0.42

0.62

0.21

Total

427

326

101

1545

1169

376

0.06

0.09

0.03

0.22

0.33

0.11

  1. aIncidence = (incident cases/total Korean population) × 105
  2. bPrevalence = (prevalent cases/total Korean population) × 105